Exercise During Active Surveillance for Localized Low-Risk Prostate Cancer: Current Evidence and a Survivorship Framework.
- 1Independent Scholar, Pittsboro, NC 27312, USA.
Abstract
Background
Active Surveillance (AS) is an established management strategy for appropriately selected men with localized low-risk prostate cancer, allowing many to defer or avoid definitive treatment while remaining under structured oncologic monitoring. Because surveillance may continue for years, survivorship needs during this period warrant greater attention.Objective
This narrative and conceptual review summarizes current evidence regarding structured exercise during AS and proposes a survivorship framework for individualized exercise prescription, including readiness monitoring as an emerging concept.Evidence synthesis
Exercise-oncology evidence and AS-specific trials support benefits in cardiorespiratory fitness and selected psychosocial outcomes. A 2024 systematic review and meta-analysis of six randomized trials (332 participants) found improved VO2peak, while effects on quality of life and PSA were less certain. Recent reviews likewise conclude that exercise and other lifestyle interventions are feasible and may provide supportive benefits, but evidence remains insufficient to demonstrate consistent effects on biopsy upgrading, MRI progression, durable deferral of treatment, or long-term prostate cancer outcomes. Readiness monitoring, including potential use of the Hooper Wellness Index, has not been validated in this population and is therefore hypothesis-generating rather than established clinical practice.Conclusions
Exercise appears well positioned as one component of a broader survivorship strategy during AS. Its current value is best supported for health, fitness, function, and well-being rather than as an anticancer treatment, and it should complement rather than replace evidence-based oncologic surveillance.
Related
- From Radical Treatment to Structured Active Surveillance: A Narrative Review of Low-Risk Localized Prostate Cancer
- Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?
- Feasibility and early outcomes of salvage robot-assisted radical prostatectomy after focal therapy failure for localized prostate cancer
- Baseline Patient and Tumour Characteristics Associated with Mental Health in Men Undergoing Active Surveillance for Prostate Cancer
- Absolute Benefit of Androgen Deprivation Therapy With Radiotherapy for Localized Prostate Cancer
BibTeX
@article{miller2026exercise,
title = {{Exercise During Active Surveillance for Localized Low-Risk Prostate Cancer: Current Evidence and a Survivorship Framework.}},
author = {Joseph A Miller},
journal = {Current oncology (Toronto, Ont.)},
year = {2026},
month = oct,
doi = {10.3390/curroncol33100599},
url = {https://europepmc.org/article/MED/42930166},
note = {CC BY},
}
RIS
TY - JOUR
TI - Exercise During Active Surveillance for Localized Low-Risk Prostate Cancer: Current Evidence and a Survivorship Framework.
AU - Joseph A Miller
PY - 2026
DA - 2026/10/03
JO - Current oncology (Toronto, Ont.)
DO - 10.3390/curroncol33100599
UR - https://europepmc.org/article/MED/42930166
AB - Background Active Surveillance (AS) is an established management strategy for appropriately selected men with localized low-risk prostate cancer, allowing many to defer or avoid definitive treatment while remaining under structured oncologic monitoring. Because surveillance may continue for years, survivorship needs during this period warrant greater attention.Objective This narrative and conceptual review summarizes current evidence regarding structured exercise during AS and proposes a survivorship framework for individualized exercise prescription, including readiness monitoring as an emerging concept.Evidence synthesis Exercise-oncology evidence and AS-specific trials support benefits in cardiorespiratory fitness and selected psychosocial outcomes. A 2024 systematic review and meta-analysis of six randomized trials (332 participants) found improved VO2peak, while effects on quality of life and PSA were less certain. Recent reviews likewise conclude that exercise and other lifestyle interventions are feasible and may provide supportive benefits, but evidence remains insufficient to demonstrate consistent effects on biopsy upgrading, MRI progression, durable deferral of treatment, or long-term prostate cancer outcomes. Readiness monitoring, including potential use of the Hooper Wellness Index, has not been validated in this population and is therefore hypothesis-generating rather than established clinical practice.Conclusions Exercise appears well positioned as one component of a broader survivorship strategy during AS. Its current value is best supported for health, fitness, function, and well-being rather than as an anticancer treatment, and it should complement rather than replace evidence-based oncologic surveillance.
SN - 1198-0052
SN - 1718-7729
ER -